Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Nasdaq Real Time Price USD

biote Corp. (BTMD)

3.4100
+0.1100
+(3.33%)
At close: April 21 at 4:00:01 PM EDT
3.5800
+0.17
+(4.99%)
After hours: April 21 at 6:25:58 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Marc D. Beer Executive Chairman 694.58k -- 1965
Mr. Robert C. Peterson Chief Financial Officer 590.96k -- 1977
Mr. Bret Christensen CEO & Director -- -- 1972
Mr. John J. Olsen Chief Information Officer -- -- 1957
Ms. Mary Elizabeth Conlon VP of Business Development, General Counsel & Corporate Secretary 552.36k -- 1981
Mr. Joel Pickering Chief Marketing Officer -- -- --
Mr. James Elliott Gibbs II Chief People Officer -- -- --
Mr. Richard Kevin Key Chief Digital Officer -- -- 1971
Mr. Jade Beutler Head of Nutraceuticals -- -- 1963
Dr. Cory Rice D.O. Chief Clinical Advisor & Member of Medical Advisory Board -- -- --

biote Corp.

1875 W. Walnut Hill Ln #100
Irving, TX 75038
United States
844 604 1246 https://www.biote.com
Sector: 
Healthcare
Full Time Employees: 
217

Description

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

Corporate Governance

biote Corp.’s ISS Governance QualityScore as of April 1, 2025 is 9. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 6; Compensation: 8.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 5, 2025 at 10:59 AM UTC - May 9, 2025 at 12:00 PM UTC

biote Corp. Earnings Date

Recent Events

April 9, 2025 at 12:00 AM UTC

POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

April 3, 2025 at 12:00 AM UTC

DEF 14A: Proxy Statements

March 17, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 14, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

March 12, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 30, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 12, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

November 8, 2024 at 12:00 AM UTC

SC 13G: Tender Offer/Acquisition Reports

October 22, 2024 at 12:00 AM UTC

SC 13G: Tender Offer/Acquisition Reports

August 8, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.